文献速递青光眼

原发性房角关闭疑似者进展的眼部生物测量危险因素:中山房角关闭预防试验

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial.
PubMed 文献 · Ophthalmology · 2021-10-08

中山房角关闭预防试验前瞻性观察643例未治疗的中国原发性房角关闭疑似(PACS)患者,随访6年,34例进展为原发性房角关闭(PAC)或急性房角关闭(AAC)。多变量模型显示基线水平房角开放距离500(AOD500)更窄、虹膜曲率(IC)更平坦及年龄更大与进展显著相关(AUC 0.73),而房角镜分级与进展无关。

要点

  • AS-OCT测量的水平AOD500变窄和虹膜曲率变平是PACS进展的独立预测因素。
  • 年龄增长与进展风险升高相关,房角镜分级不能预测进展。
  • 基线生物测量有助于对早期房角关闭患者进行风险分层。

核心结论

  • 眼部生物测量参数可帮助对早期房角关闭患者进行风险分层,预测从PACS向PAC或AAC的进展。

研究设计与样本

  • 前瞻性观察研究,纳入643例未治疗的中国大陆PACS患者,分析643只眼(609只未进展,34只进展)。

主要发现

  • 多变量连续参数模型中,基线水平AOD500每减少0.01 mm的OR为1.10(P=0.03),水平IC每减少0.1 mm的OR为1.96(P=0.01),年龄每增加1岁的OR为1.11(P=0.01),AUC为0.73。
  • 用累积房角镜评分替换水平AOD500后,房角镜评分每减少1个改良Shaffer分级与进展无显著关联(OR 1.03,P=0.85)。
  • 多变量分类参数模型中,水平AOD500最低四分位组OR为3.10(P=0.002),IC最低四分位组OR为2.48(P=0.014),年龄≥59岁OR为2.68(P=0.01),AUC为0.72。

关键数值与推荐

  • PACS定义为静态房角镜下至少2个象限无法看到色素性小梁网。
  • PAC定义为眼压高于24 mmHg或出现周边虹膜前粘连。
  • 进展定义为发生PAC或AAC发作。
  • 主要结局为6年从PACS进展为PAC或AAC。

临床怎么用

  • 临床可借助AS-OCT测量的房角与虹膜生物参数对PACS患者进行进展风险评估。
  • 房角镜分级单独用于预测进展的价值有限,应结合生物测量指标综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess baseline ocular biometric risk factors for progression from primary angle closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC). DESIGN: Prospective, observational study. PARTICIPANTS: Six hundred forty-three mainland Chinese with untreated PACS. METHODS: Participants underwent baseline clinical examinations, including gonioscopy, anterior segment OCT (AS-OCT) imaging, and A-scan ultrasound biometry as part of the Zhongshan Angle Closure Prevention (ZAP) Trial. Primary angle closure suspect was defined as an inability to visualize pigmented trabecular meshwork in 2 or more quadrants based on static gonioscopy. Primary angle closure was defined as development of intraocular pressure above 24 mmHg or peripheral anterior synechiae. Progression was defined as development of PAC or an AAC attack. Multivariable logistic regression models were developed to assess biometric risk factors for progression. MAIN OUTCOME MEASURES: Six-year progression from PACS to PAC or AAC. RESULTS: Six hundred forty-three untreated eyes (609 nonprogressors, 34 progressors) of 643 participants were analyzed. In a multivariable model with continuous parameters, narrower horizontal angle opening distance of 500 μm from the scleral spur (AOD500; odds ratio [OR], 1.10 per 0.01-mm decrease; P = 0.03), flatter horizontal iris curvature (IC; OR, 1.96 per 0.1-mm decrease; P = 0.01), and older age (OR, 1.11 per 1-year increase; P = 0.01) at baseline were associated significantly with progression (area under the receiver operating characteristic curve [AUC], 0.73). Smaller cumulative gonioscopy score was not associated with progression (OR, 1.03 per 1-modified Shaffer grade decrease; P = 0.85) when replacing horizontal AOD500 in the multivariable model. In a separate multivariable model with categorical parameters, participants in the lowest quartile of horizontal AOD500 (OR, 3.10; P = 0.002) and IC (OR, 2.48; P = 0.014) measurements and 59 years of age or older (OR, 2.68; P = 0.01) at baseline showed higher odds of progression (AUC, 0.72). CONCLUSIONS: Ocular biometric measurements can help to risk-stratify patients with early angle closure for more severe disease. Anterior segment OCT measurements of biometric parameters describing the angle and iris are predictive of progression from PACS to PAC or AAC, whereas gonioscopy grades are not.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Xu BY, Friedman DS, Foster PJ, et al. Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial. Ophthalmology. 2021. PMID: 34634364. doi:10.1016/j.ophtha.2021.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。